Repeat data integrity lapses during internal audit – 483 risk assessment
Addressing Recurrent Data Integrity Issues During Internal Audits In today’s highly regulated pharmaceutical landscape, repeat data integrity lapses during internal audits can lead to serious compliance risks, including potential 483…